• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ADMEDUS REGEN PTY LTD CARDIOCEL NEO; INTRACARDIAC PATCH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ADMEDUS REGEN PTY LTD CARDIOCEL NEO; INTRACARDIAC PATCH Back to Search Results
Catalog Number UC0508N
Device Problem Insufficient Information (3190)
Patient Problem Stenosis (2263)
Event Date 05/25/2021
Event Type  Injury  
Event Description
Pulmonary atresia with vsd, ductal stent placed in neonatal period then (b)(6) 2021 complete repair with vsd closure, transannular patch (cardiocel) and lpa plasty (cardiocel).Lpa occluded, requiring stent placement.Then developed significant rv outflow tract obstruction, redo operation in (b)(6) 2022 with patch augmentation of prior transannular patch.Endothelialized surface inside the transannular patch was very thickened, leading to a focal stenosis where the pulmonary annulus would have been (nearly circumferential cardiocel here).Tried to "thin out" the native pulmonary annulus but was actually very thin, thickening was all the patch material.Revised with an autologous pericardial patch, leaving some cardiocel at the distal pa where it appeared visually widely patent.On followup, the area where cardiocel remained in the distal main pa is now severely stenotic and planning for cath to attempt to balloon it.Echo (b)(6) 21 prompted decision to reoperate, delayed multiple times due to uri and uti and then redo sternotomy in (b)(6) 2022.Ct (b)(6) 2022 demonstrated residual stenosis at distal mpa, the one area with residual cardiocel patch material.
 
Manufacturer Narrative
Review of batch record did not identify any deviations or errors.Investigation and interviews with clinicians have been scheduled.Adverse events associated with bioprosthetic pericardial patches that have been reported in the literature, have included flow obstruction.
 
Manufacturer Narrative
Review of batch record did not identify any deviations or errors.Investigation has been completed and interviews with clinicians have been performed.The events occurred in 7 patients out of 140 treated with cardiocel.A call with physicians occurred to discuss the procedure and their findings.It was noted the events happened in cases of pa repair.Batch record review determined that all products met acceptance criteria.There were no manufacturing changes during this time period to suggest a change on the product.While anteris continues to monitor, it appears at this time the event to be unlikely related to the product but rather associated with the complex intervention and challenges of vascular reconstruction in these young patients.
 
Event Description
Pulmonary atresia with vsd, ductal stent placed in neonatal period then (b)(6) 2021 complete repair with vsd closure, transannular patch (cardiocel) and lpa plasty (cardiocel).Lpa occluded, requiring stent placement.Then developed significant rv outflow tract obstruction, redo operation in (b)(6) 2022 with patch augmentation of prior transannular patch.Endothelialized surface inside the transannular patch was very thickened, leading to a focal stenosis where the pulmonary annulus would have been (nearly circumferential cardiocel here).Tried to "thin out" the native pulmonary annulus but was actually very thin, thickening was all the patch material.Revised with an autologous pericardial patch, leaving some cardiocel at the distal pa where it appeared visually widely patent.On followup, the area where cardiocel remained in the distal main pa is now severely stenotic and planning for cath to attempt to balloon it.Echo (b)(6) 2021 prompted decision to reoperate, delayed multiple times due to uri and uti and then redo sternotomy in (b)(6) 2022.Ct (b)(6) 2022 demonstrated residual stenosis at distal mpa, the one area with residual cardiocel patch material.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARDIOCEL NEO
Type of Device
INTRACARDIAC PATCH
Manufacturer (Section D)
ADMEDUS REGEN PTY LTD
26 harris road
malaga, western australia 6080
AS  6080
Manufacturer (Section G)
ADMEDUS REGEN PTY LTD
26 harris road
malaga, western australia 6080
AS   6080
Manufacturer Contact
jim chapman
860 blue gentien road
suite 340
eagan, MN 55121
6514930606
MDR Report Key15739054
MDR Text Key303145993
Report Number3012664855-2022-00007
Device Sequence Number1
Product Code DXZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130872
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Distributor
Reporter Occupation Risk Manager
Type of Report Initial,Followup
Report Date 02/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/04/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/13/2023
Device Catalogue NumberUC0508N
Device Lot NumberM20028-02
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/05/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/26/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Hospitalization;
Patient Age19 MO
Patient SexFemale
Patient Weight8 KG
-
-